26% of these patients were subsequently recommended endocrine therapy alone, as guided by the residual recurrence estimates provided by the score, and hence sparing a significant proportion of women the potential short and long-term toxicities of chemotherapy, as well as sparing health-care providers...
John Flanigan (Center for Global Health, National Cancer Institute, Bethesda, MD), Dr. Jane Brock (Department of Pathology, Brigham and Women’s Hospital, Boston MA), Dr. Dan Milner (American Society for Clinical Pathology, Chicago, IL), and Dr. Carol Harris (Department of Medicine, Albert...